ENNOV acquired by BREGAL SAGEMOUNT & ARDIAN
Context
The transaction represents a transition of ownership from a founder-led corporate structure to a sponsor-backed primary LBO. The core industrial rationale of the ownership transfer is to match the target's capital structure with its cross-border scaling ambitions, specifically accelerating market share gains in the high-volume North American life sciences software sector. The timing of the transaction reflects the inflection point where the target requires institutional private equity expertise and global capital to scale its commercial distribution network. Post-acquisition, the strategic focus will prioritize aggressive investment in international go-to-market execution, technological R&D to embed enterprise-grade AI capabilities, and broader product suite expansion. The transaction is capitalized via a unitranche debt facility provided by a US credit fund, engineered to deliver the long-term balance sheet flexibility required for rapid product and commercial scaling. Continuity of leadership is maintained, with the founder and existing management team retaining executive control to execute the next growth phase.
ENNOV, which reported an EBITDA margin of LOGIN in 2025, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN to the average currently observed in the TMT (Tech, Media, Telecom) sector (14.8x).
Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.
-> Deep-dive in TMT (Tech, Media, Telecom) market trends
Target
Ennov functions as a mission-critical infrastructure software provider tailored for the life sciences and healthcare ecosystems, which are defined by rigorous, ever-evolving compliance mandates enforced by global regulatory bodies like the FDA and the EMA. The target’s competitive positioning relies on replacing fragmented, legacy point solutions with a unified software platform that centralizes highly sensitive workflows, including regulatory affairs, pharmacovigilance, clinical trials, and quality management. The business model is driven by a predictable SaaS and cloud subscription revenue architecture sold to a global pharmaceutical and biotechnology customer base. Given the deeply embedded nature of regulatory systems in life sciences workflows, the target benefits from exceptionally high customer switching costs, driving strong net retention rates and long-term cash flow visibility. The primary value driver resides in the integration of data and content management onto a single database, which directly reduces time-to-market for clinical pipelines while eliminating cross-border compliance risks. ARR expansion is further fueled by the monetisation of advanced automated data-processing modules powered by artificial intelligence.
Ent. Value
LOGIN
Equity Value
LOGIN
Multiples
EV / Revenue
LOGIN
EV / EBITDA
LOGIN
EV / EBIT
LOGIN
Historical Financials (EUR)
Similar deals in TMT (Tech, Media, Telecom)
| Date | Acquirer | Target | Country | Sector | Deal Context |
|---|---|---|---|---|---|
| 06/2026 | INTEGRATED MEDIA COMPANY | PLAYSTACK | UNITED KINGDOM | Software | Integrated Media Company (IMC), through its subsidiary VantageCo Limited, has completed the acquisition of Playstack Limited, a leading independent UK-based video game publisher specializing in digital title releases across PC, console, and mobile platforms |
| 06/2026 | ASYS | M-WORK | FRANCE | Software | The acquisition of m-work shifts Asys’s product perimeter from legacy time-and-attendance tracking into upstream collaborative workforce scheduling and hybrid physical asset optimization. Executed with follow-on programmatic M&A backing from CAPZA through its Growth Tech investment vehicle, this transaction accelerates Asys’s product roadmap by injecting native AI capabilities into its core scheduling engine to target pan-European corporate accounts |
| 05/2026 | DOCTOLIB | MEDICUS | United Kingdom | Software | Doctolib executed a strategic acquisition of Medicus, a UK-based developer of clinical software for the National Health Service (NHS), marking its official entry into the United Kingdom. This transaction represents a key milestone in Doctolib's European expansion, adding the UK as its fifth operational market alongside France, Germany, Italy, and the Netherlands |
| 05/2026 | LATTICE SEMICONDUCTOR | AMI | UNITED STATES | Software | Lattice Semiconductor has agreed to acquire AMI in a strategic transaction designed to create a comprehensive secure management and control platform for the technology industry. The acquisition is a key step in advancing Lattice's strategy to expand its market position in high-growth server, AI, and cloud applications |
| 05/2026 | PUBLICIS GROUPE | LIVERAMP | UNITED STATES | Software | Publicis Groupe has entered into a definitive agreement to acquire 100% of the share capital of US-based LiveRamp through an all-cash public tender offer. This landmark cross-border transaction represents Publicis' largest tech-driven acquisition since Epsilon, explicitly engineered to accelerate the group's digital capabilities in secure data co-creation, advanced data clean rooms, and agentic AI enterprise transformation |
| 05/2026 | OAKLEY CAPITAL INVESTMENTS | XTEL | BELGIUM | Software | Pan-European private equity investor Oakley Capital has entered into an agreement to acquire a majority equity stake in enterprise software provider XTEL. The transaction is being executed alongside existing shareholders Bain Capital and SilverTree Equity, with the latter remaining invested to actively support the company's next phase of growth |
| 05/2026 | LEGALPLACE | LEGALSTART | France | Software | LegalPlace has completed the full acquisition of its historical and primary competitor, Legalstart, marking a major consolidation event within the French LegalTech landscape. The transaction was financed as part of a significant capital increase by LegalPlace, backed by a consortium of investors including Move Capital Fund I, XAnge, and Eurazeo |
| 04/2026 | LONG PATH PARTNERS | IDOX | UNITED KINGDOM | Software | Long Path Partners has declared its all-cash offer for Idox plc unconditional, completing the acquisition process. The transaction involves the transfer of 100% of the share capital of the London-listed software business to the U.S... |
| 04/2026 | IKS HEALTH | TRUBRIDGE | UNITED STATES | Software | IKS Health has entered into a definitive agreement to acquire 100% of the equity of TruBridge Inc. through its U.S. arm. The acquisition is a strategic move to create a comprehensive "system of record plus system of action" platform |
| 04/2026 | TEAMSYSTEM | ACD | FRANCE | Software | TeamSystem, a leading digital platform backed by Hellman & Friedman, Silver Lake, and CapitalG, has successfully finalized the acquisition of ACD in France. This strategic move represents the fourth transaction of the group in 2026, marking a significant acceleration of its international expansion strategy |
REFERENCES
Valuation range: EV 300M - 700M EUR
Revenue range: 50M - 100M EUR
EBITDA range: 10M - 30M EUR
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of ENNOV by BREGAL SAGEMOUNT / ARDIAN are reserved for mynth community members. Register for free to unlock full data.
Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).
Press release: view release
Target: ennov
Acquirer: ardian / bregal sagemount